on 25 Jan 2023
Last Applicant/ Owned by
Xeris Pharmaceuticals, Inc.
180 N LaSalle Street, Suite 1810Chicago IL 60601
US
Serial Number
2126390 filed on 5th Mar 2021
Registration Number
TMA1162771 registered on 25th Jan 2023
Registration expiry Date
5th Mar 2031Trademark usage description
providing information on the topics of diabetes and pharmaceuticals for treating diabetes.Vienna Information
1 . 15 . 15
DropsGouttes
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 2 . 7
Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
CIPO Classification Code
Nice
11
2126390
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 222 on 31st Oct 2022 | Opposition Start Date Notice Sent |
Submitted for opposition 26 on 4th Oct 2022 | Approved |
Submitted for opposition 27 on 4th Oct 2022 | Approval Notice Sent |
Submitted for opposition 22 on 27th Sept 2022 | Search Recorded |
Submitted for opposition 256 on 13th Jun 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 12th Aug 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 11th Aug 2021 | Created |
Submitted for opposition 31 on 11th Aug 2021 | Formalized |
Submitted for opposition 30 on 5th Mar 2021 | Filed |
Submitted for opposition 228 on 5th Mar 2021 | International Registration |